Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05533359 · ClinicalTrials.gov registry record · NA
SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 2,117
- Enrollment target
NCT05533359: Completed NA study, sponsored by University of Utah.
NCT05533359 is a NA study that has completed, run by University of Utah. The registered enrollment target is 2,117 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05533359, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,117 participants
- Enrollment target
Study Summary
The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team has established population health management (PHM) interventions that have been used since Feb 2021 to increase the uptake of COVID-19 testing and vaccination among community health center patients. Interventions are based on a PHM approach that uses widely available technology (i.e. cell phones and text messaging). SCALE-UP II will both build on SCALE-UP Utah PHM interventions and investigate novel resource conservation approaches (i.e., Request-Patient Navigation vs. No Patient Navigation and text messaging vs. conversational agent). SCALE-UP II builds on long standing partnerships among the University of Utah Clinical and Translational Science Institute (UofU CTSI), Association for Utah Community Health (AUCH), CHCs, and the Utah Department of Health(UDOH). CTSI and SCALE-UP II investigators are leading several COVID-19 initiatives that drive public health response and state government policies in Utah. Thus, the UofU team is uniquely positioned to lead this project.
Primary Outcome
Number of patients who requested a test kit and confirmed their mailing address.
Interventions
- BEHAVIORAL Patient Navigation (PN)
- BEHAVIORAL Text-Messaging (TM)
- BEHAVIORAL Conversational Agent (CA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,117 participants |
| Start Date | 2023-01-15 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
What the finished NCT05533359 record still lists
NCT05533359 is an interventional study that assigns participants to a tested intervention. Its 2,117 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% higher).
The record links to 0 conditions, and to 3 interventions - of which Patient Navigation (PN) is the first listed.
NCT05533359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05533359 about?
NCT05533359 is a clinical study titled "SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study". The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team has established population health management (PHM) interventions that have been used since Feb 2021...
What is the current status of trial NCT05533359?
This trial is currently completed. It is a NA study. The enrollment target is 2,117 participants. The study started on 2023-01-15. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT05533359?
The interventions under investigation include: Patient Navigation (PN) (BEHAVIORAL), Text-Messaging (TM) (BEHAVIORAL), Conversational Agent (CA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05533359?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05533359's enrollment target sits among peer trials
2,117 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT05967273 · 2,106 participants · NA
CirrhosisRx CDS System
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI